Fig. 1
From: Thrombocytosis in patients with spondyloarthritis: a case–control study
Platelet count in spondyloarthritis patients with thrombocytosis treated with anti-TNF-α therapy and conventional therapy. * p < 0.05 for 31 spondyloarthritis patients with thrombocytosis treated with conventional therapy between week 12 and week 0. ** p < 0.05 for 38 spondyloarthritis patients with thrombocytosis treated with anti-TNF-α therapy between week 6 and week 0. *** p < 0.05 for 38 spondyloarthritis patients with thrombocytosis treated with anti-TNF-α therapy between week 12 and week 0